About Us

EnBioAdvice is pioneering a novel multidisciplinary approach for the effective and safe management of airborne and environmental related diseases where aerosols containing causal pathogens and particulate matter are well established. EnBioAdvice’s platform focus on widespread pollutant aerosols (PM2.5), hazardous chemical residues and pandemic airborne diseases with an unmet medical need.

EnBioAdvice’s combined in-house expertise and services mirror key functions in the life cycle of our products; an integration of nanoengineering and biotechnology expertise to deliver the zero-net energy ventilation device and a pollution free indoor atmosphere.

EnBioAdvice provides both advanced innovatiove solutions and consultancy services on matters related to airborne, pollutants and aerosol particulate matter. We provide advice on whether your particular project and organisation can benefit from our innovative devices and long-term preventative approach.

EnbBioAdvice will provide you with a report on our assessment of your particular project.
EnbioAdvice is trading for the Trustee for Sheeba Investments & P.D. Pty Ltd.
To discuss further possibilities for collaborations please contact our office.

Approach

In our R&D projects, biotech-scientists and nano-engineers collaborate for the development of high performance devices and high-end processes, which need to be precisely adjusted for desired structure and function to deliver significant reduction in aerosol containing pollutions.
It is our highest goal to develop safe devices relying on renewable energy that can both save lives and improve today’s lifestyle. Therefore, our devices are manufactured following our holistic quality management system. To confirm central quality elements such as compatibility and interchangeability, our product candidates are produced with modular components and undergo a massive characterization program. The safety and suitability of our products are strictly controlled in full compliance with regulatory requirements.
Our exclusive zero-net-energy nano- and biotech-integrated portfolio respects the need for affordable products, thorough market analyses, patent research and evaluation of the technical and users-friendly development demand. Thereby, we are creating proprietary intellectual property, while generating additional benefits for users.
We utilize modular manufacturing technologies to enable rapid capacity adjustments. Moreover, the use of renewable energy allows for a energy efficient and sustainable process manufacturing and thus for a local production in developed as well as emerging markets.
EnBioAdvice’s development programs are further strengthened by leading contract manufacturing and analytical research organizations. Our partners provide the compliant manufacturing of supplies. They contribute to our extensive scientific and technical approach with a battery of cutting-edge analytical methods and provide support in formulation and technical device development.
Leading experts from biotechnology and nano-engineering industry support our development programs by contributing their experience and expertise from various perspectives, such as manufacturing, quality, health, and regulatory.